Experimental Mouse Resources Core

实验鼠标资源核心

基本信息

项目摘要

The Cooperative Centers of Excellence in Hematology (CCEH) will be utilized by investigators for in vivo studies focused on molecular and cellular mechanisms involved in steady state hematopoiesis, the bone marrow niche, BM transplantation, and immune cell function. Centralization will prevent duplication of resources, ensure consistent supply of acclimated mice, and maintain high quality research infrastructure essential for conducting in vivo studies of hematopoietic stem and progenitor cell (HSPC) function. The Experimental Mouse Resources Core (EMRC) will provide CCEH investigators advanced resources for their studies using mice for murine and human transplantation models. The specific aims of the EMRC are: 1. Maintain on-site breeding colonies of essential mice to study human and murine hematopoiesis in vivo. For investigations focused on human hematopoiesis, colonies of NOD.Cg-PrkdcscidIl2rgtm1Wjl/J (NSG) and NOD.Cg-Ragtm1MomIl2rgtm1Wjl/SzJ and (NRG) immunodeficient mice will be maintained. In anticipation of future needs, a starter colony of the triple transgenic NSG-SGM3 (NSGS) mice that express human IL3, GM-CSF and SCF has been established and can be expanded as needed. Breeding colonies of C57/BL/6J, B6.SJL-Ptprca Pepcb/BoyJ (Boy/J), and the BoyJ x C57BL/6J (F1 cross) mouse strains will be maintained. The F1 cross is a unique strain and is not commercially available. Congenic mouse strains allow for simultaneous tracking of donor, competitor, and recipient cells. 2. Provide specialized core services and consultation to CCEH investigators. EMRC personnel will conduct irradiations, transplantations, serial sampling of peripheral blood, and compound dosing. The Core will harvest and provide tissues from transplanted mice to investigators for detailed analysis by the CCEH Flow and Tissue Cytometry Core. The ERMC will work closely with the Hypoxia Core to coordinate transplant of mouse and human HSPC collected and processed under hypoxia versus ambient air (Mantel et al., Cell 2015). The EMRC Director will coordinate with Core personnel all procedures, experimental design, methodology, and data interpretation. Expertise and infrastructure is in place to facilitate all aspects of BMT studies seamlessly for on-site CCEH members as well as PIs on a national level. 3. Serve as an educational resource for CCEH laboratories. Exceptional connectivity between the EMRC and the other biomedical cores as well as the Enrichment core will augment the research and training activities of the CCEH membership and their trainees. Training in the execution of high-quality in vivo studies will be a critical and essential component in training our next generation of scientists to be successful in research careers dedicated to the study of nonmalignant hematology. 4. Work in concert with other CCEH centers and investigators Nationwide to provide EMRC services to the community of scientists involved in nonmalignant hematology research.
研究者将利用血液学卓越合作中心(CCEH)进行体内研究。 研究集中在稳态造血、骨生成、骨再生、骨 骨髓生态位、骨髓移植和免疫细胞功能。集中化将防止重复 资源,确保驯化小鼠的持续供应,并保持高质量的研究基础设施 这对于进行造血干细胞和祖细胞(HSPC)功能的体内研究至关重要。的 实验小鼠资源核心(EMRC)将为CCEH研究人员提供先进的资源, 使用小鼠作为鼠和人移植模型的研究。该公司的具体目标是: 1.维持基本小鼠的现场繁殖集落,以研究人类和小鼠的造血, vivo.对于关注人造血的研究,NOD. Cg-PrkdcscidIl 2 rgtm 1 Wjl/J(NSG)的菌落 和NOD. Cg-Ragtm 1 MomI 12 rgtm 1 Wjl/SzJ和(NRG)免疫缺陷小鼠。由于预期 未来需要,表达人IL 3的三重转基因NSG-SGM 3(NSGS)小鼠的起始集落, GM-CSF和SCF已经建立,并可根据需要扩大。繁殖群体 C57/BL/6 J、B6.SJL-Ptprca Pepcb/BoyJ(Boy/J)和BoyJ x C57 BL/6 J(F1杂交)小鼠品系将 树立政治意识F1杂交是一种独特的菌株,没有市售。同类系小鼠 允许同时追踪供体、竞争者和受体细胞。 2.为CCEH调查员提供专业的核心服务和咨询。机电工程管理局人员会 进行辐照、移植、外周血系列采样和化合物给药。核心 将采集移植小鼠的组织并提供给研究人员,供CCEH进行详细分析 流式细胞术和组织细胞术核心。ERMC将与低氧核心密切合作, 在低氧与环境空气下收集和处理的小鼠和人HSPC移植物(Mantel 例如,Cell 2015)。EMRC主任将与核心人员协调所有程序、实验 设计、方法和数据解释。专业知识和基础设施到位,以促进所有方面 为现场CCEH成员以及国家层面的PI提供无缝的BMT研究。 3.作为CCEH实验室的教育资源。与EMRC之间的卓越连接 其他生物医学核心以及浓缩核心将加强研究和培训 CCEH会员及其学员的活动。在执行高品质的培训在体内 研究将是培养我们下一代科学家的关键和必要组成部分, 在致力于非恶性血液学研究的研究事业中取得成功。 4.与全国其他CCEH中心和调查人员合作,为以下人员提供EMRC服务: 参与非恶性血液学研究的科学家团体。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Karen Elizabeth Pollok其他文献

Karen Elizabeth Pollok的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Karen Elizabeth Pollok', 18)}}的其他基金

Experimental Mouse Resources Core
实验鼠标资源核心
  • 批准号:
    10681258
  • 财政年份:
    2015
  • 资助金额:
    $ 15.44万
  • 项目类别:
Enrichment Program
强化计划
  • 批准号:
    10681266
  • 财政年份:
    2015
  • 资助金额:
    $ 15.44万
  • 项目类别:
Enrichment Program
强化计划
  • 批准号:
    10206542
  • 财政年份:
    2015
  • 资助金额:
    $ 15.44万
  • 项目类别:
Experimental Mouse Resources Core
实验鼠标资源核心
  • 批准号:
    10473856
  • 财政年份:
    2015
  • 资助金额:
    $ 15.44万
  • 项目类别:
Enrichment Program
强化计划
  • 批准号:
    10473865
  • 财政年份:
    2015
  • 资助金额:
    $ 15.44万
  • 项目类别:
Dual Targeting of DNA Repair and p53 pathways for treatment of brain cancer
DNA 修复和 p53 通路双重靶向治疗脑癌
  • 批准号:
    7986836
  • 财政年份:
    2010
  • 资助金额:
    $ 15.44万
  • 项目类别:
Dual Targeting of DNA Repair and p53 pathways for treatment of brain cancer
DNA 修复和 p53 通路双重靶向治疗脑癌
  • 批准号:
    8110715
  • 财政年份:
    2010
  • 资助金额:
    $ 15.44万
  • 项目类别:
Dual Targeting of DNA Repair and p53 pathways for treatment of brain cancer
DNA 修复和 p53 通路双重靶向治疗脑癌
  • 批准号:
    8473057
  • 财政年份:
    2010
  • 资助金额:
    $ 15.44万
  • 项目类别:
Dual Targeting of DNA Repair and p53 pathways for treatment of brain cancer
DNA 修复和 p53 通路双重靶向治疗脑癌
  • 批准号:
    8676458
  • 财政年份:
    2010
  • 资助金额:
    $ 15.44万
  • 项目类别:
In Vivo Therapeutics Core
体内治疗核心
  • 批准号:
    10247608
  • 财政年份:
    1999
  • 资助金额:
    $ 15.44万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.44万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 15.44万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 15.44万
  • 项目类别:
    Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 15.44万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 15.44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 15.44万
  • 项目类别:
    Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
  • 批准号:
    2230829
  • 财政年份:
    2023
  • 资助金额:
    $ 15.44万
  • 项目类别:
    Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 15.44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 15.44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 15.44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了